BeyondSpring gains options for Fred Hutch programs

BeyondSpring Pharmaceuticals Inc. (New York, N.Y.) began a five-year partnership with Fred Hutchinson Cancer Research Center (Seattle, Wash.) to develop cancer treatments and diagnostics.

The hybrid U.S.-China co-development company will have the option to license undisclosed therapeutic and diagnostic oncology projects from Fred Hutchinson, which will offer BeyondSpring up to six projects each year. BeyondSpring said it would fund preclinical and clinical studies under the partnership. Financial details were undisclosed. ...